top of page

Welcome to Clinical Research at Mission Dermatology


Message from our Principal Investigator

Shireen V. Guide, MD, FAAD

At Mission Dermatology, we are committed to advancing the medical treatment of skin diseases through clinical research. Our team of experienced researchers and dermatologists is dedicated to providing alternative care options to our patients.

Trials open for enrollment​​

A placebo-controlled trial to evaluate the efficacy and safety of spesolimab in the treatment of patients with Netherton Syndrome

A phase 3 randomized, double-blind, 52-week placebo-controlled multi-center study, with 52-week randomized dose up/dose down titration extension period, investigating the efficacy, safety, and tolerability of Ritlecitinib in adult participants with nonsegmental vitiligo.

A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis

We are currently enrolled in several clinical trials researching an array of skin cancers including basal cell carcinoma, squamous cell carcinoma and melanoma. 

A two-stage double-blind, randomized, placebo-controlled study to assess the efficacy, safety and pharmacokinetics of alpelisib in pediatric and adult patients with lymphatic malformations associated with a PIK3CA mutation.

Latest News & Updates

bottom of page